Article Versions Notes

Hansen AW, Vestergaard P, Poulsen MM, Rasmussen ÅK, Feldt-Rasmussen U, Madsen M, Næraa RW, Hansen D, Main K, Pedersen HB, et al. RET C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Study. Cancers. 2025; 17(3):374. https://doi.org/10.3390/cancers17030374

Hansen, Anders Würgler, Peter Vestergaard, Morten Møller Poulsen, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Mette Madsen, Rune Weis Næraa, Dorte Hansen, Katharina Main, Henrik Baymler Pedersen, and et al. 2025. "RET C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Study" Cancers 17, no. 3: 374. https://doi.org/10.3390/cancers17030374

Hansen, A. W., Vestergaard, P., Poulsen, M. M., Rasmussen, Å. K., Feldt-Rasmussen, U., Madsen, M., Næraa, R. W., Hansen, D., Main, K., Pedersen, H. B., Londero, S. C., Rolighed, L., Hahn, C. H., Rask, K. B., Maare, C., Nielsen, H. H., Gaustadnes, M., Rossing, M., Hermann, P., & Mathiesen, J. S., on behalf of Danish Thyroid Cancer Group (DATHYRCA). (2025). RET C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Study. Cancers, 17(3), 374. https://doi.org/10.3390/cancers17030374